Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie

FTSE 100 Live: Bank of England expected to cut interest rates

AstraZeneca and Watches of Switzerland will be in focus ahead of the Bank of Englands rate decision on Thursday. AstraZeneca…

FTSE 100 Live: Index smashes record as Bank of England cuts interest

FTSE 100 jumps 131 points, sets record at 8,767 BoE cuts interest by 0.25% to 4.50% AstraZeneca surges on earnings beat 2.14pm:…

FTSE 100 Live: Index notches new record; Bank of England set to cut interest

FTSE 100 jumps 67 points, sets record at 8,695 BoE expected to cut interest AstraZeneca among risers on update 8.33am: Compass…

FTSE 100 Live: Index passes 8,700 for new record; Bank of England set to cut interest

FTSE 100 jumps 113 points, sets record at 8,736 BoE expected to cut interest AstraZeneca surges on earnings beat 10.50am: BoE expected…

Bank of England, AstraZeneca, Watches of Switzerland: Thursday ahead

AstraZeneca and Watches of Switzerland will be in focus ahead of the Bank of Englands rate decision on Thursday. AstraZeneca…

Lowey Dannenberg Notifies AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…

CHMP Gives Nod to Expanded Use of J&Js Rybrevant & AZNs Imfinzi

The CHMP recommends approval for JNJs subcutaneous formulation of Rybrevant in NSCLC and AstraZenecas Imfinzi in limited-stage small-cell lung cancer.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioAge, AstraZeneca, FTAI, and Revance and Encourages Investors to Contact the Firm

NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Total Voting Rights

3 February 2025 Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct Authoritys Disclosure…

Imfinzi recommended for EU approval for LS-SCLC

3 February 2025 Imfinzi recommended for approval in the EU by CHMP as first and only immunotherapy for limited-stage small cell lung…

dpa-AFX ProFeed